Cross-national disparities in drug interaction reporting and assessment between Switzerland and Austria: A retrospective, registry-based study using pharmacovigilance data
Marcel Rainer, Adrian Martinez De la Torre, Romuald Bellmann, Andrea Michelle Burden, Stefan Weiler · 2026
Read Cross-national disparities in drug interaction reporting and assessment between Switzerland and Austria: A retrospective, registry-based study using pharmacovigilance data by Marcel Rainer, Adrian Martinez De la Torre, Romuald Bellmann, Andrea Michelle Burden, Stefan Weiler (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0356774.txt.
Description
Marcel Rainer and four colleagues compare how two neighboring countries handle reports of harmful drug interactions, in a 2026 study of safety registries. Switzerland and Austria have similar health systems but organize their drug safety monitoring differently. The team analyzed roughly fifteen hundred interaction reports filed in the two countries over a period of more than sixteen years.
Switzerland filed well over three times as many reports as Austria relative to its reporting rate, and most reports in both countries described serious outcomes. Taking many medicines at once was strongly tied to serious harm in both systems. The content differed too: Swiss reports more often described the mechanism of a problem, while Austrian ones more often described symptoms. The authors suggest that who processes the reports, including whether specialists are involved, shapes what a safety system learns.
Catalog record
| CREATOR | Marcel Rainer, Adrian Martinez De la Torre, Romuald Bellmann, Andrea Michelle Burden, Stefan Weiler |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 34305 |
| LICENSE | CC_BY |
| RIGHTS | CC BY |
| SOURCE | PLOS |